Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: BURL stock price vs REGN: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at REGN's multiple
Needs REGN P/E.
Implied fair value · at BURL's multiple
Needs BURL P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: BURL FY 2026 (ended Jan 31, 2026) · REGN FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 89% equity / 11% debt · EV / Revenue 1.51x · EV / EBITDA 13.77x
Capital structure 98% equity / 2% debt · EV / Revenue 4.99x · EV / EBITDA 13.12x
REGN carries the larger enterprise value at $71.53B against $17.51B; BURL trades on the lower EV / Revenue multiple (1.51x vs 4.99x); REGN on the lower EV / EBITDA (13.12x vs 13.77x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
BURLINGTON STORES, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
REGENERON PHARMACEUTICALS, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
1.15x
0.06x
Net debt / EBITDA
Leverage against operating earnings
0.67x
-1.21x
Cash and equivalents
Liquid reserves on the balance sheet
$1.23B
$8.61B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
TJX COMPANIES INC /DE/
BURL vs TJX
ROSS STORES, INC.
BURL vs ROST
DILLARD'S, INC.
BURL vs DDS
Walmart Inc.
BURL vs WMT
COSTCO WHOLESALE CORP /NEW
BURL vs COST
AMGEN INC
BURL vs AMGN
PFIZER INC
BURL vs PFE
BRISTOL MYERS SQUIBB CO
BURL vs BMY
BIOGEN INC.
BURL vs BIIB
GILEAD SCIENCES, INC.
BURL vs GILD
Seagate Technology Holdings plc
BURL vs STX
$2.08B
$1.99B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
